LifeMD, Inc.
For the period ended Jun 30, 2026. Filed Aug 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 5, 2026
LFMD$1.74-16.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity (Deficit)
Consolidated STATEMENTS of CHANGES IN STOCKHOLDERS’ EQUITY (Deficit)
| LifeMD, Inc. | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Series A Preferred Stock · Common Stock · Additional Paid-in · Accumulated · Treasury · Non-controlling Interest of Discontinued | ||||||||||
| Shares | Amount | Shares | Amount | Capital | Deficit | Stock | Total | Operations | Total | |
| Balance, January 1, 2025 | 1,400,000 | $140 | 42,293,907 | $422,939 | $230,508,339 | $(239,850,931) | $(163,701) | $(9,083,214) | $1,529,094 | $(7,554,120) |
| Stock compensation expense | - | - | 1,282,654 | 12,827 | 2,535,701 | - | - | 2,548,528 | - | 2,548,528 |
| Cashless exercise of stock options | - | - | 56,139 | 561 | (56) | - | - | - | - | - |
| Series A Preferred Stock Dividend | - | - | - | - | - | (776,563) | - | (776,563) | - | (776,563) |
| Distribution to non-controlling interest of discontinued operations | - | - | - | - | - | - | - | - | (36,000) | (36,000) |
| Net (loss) income | - | - | - | - | - | (183,778) | - | (183,778) | 531,845 | 348,067 |
| Balance, March 31, 2025 | 1,400,000 | $140 | 43,632,700 | $436,327 | $233,043,479 | $(240,811,272) | $(163,701) | $(7,495,027) | $2,024,939 | $(5,470,088) |
| Stock compensation expense | - | - | 346,250 | 3,463 | 2,091,151 | - | - | 2,094,614 | - | 2,094,614 |
| Cashless exercise of stock options | - | - | 50,119 | 501 | (501) | - | - | - | - | - |
| Cashless exercise of warrants | - | - | 390,115 | 3,901 | (3,901) | - | - | - | - | - |
| Stock issued for debt conversion | - | - | 672,042 | 6,720 | 993,280 | - | - | 1,000,000 | - | 1,000,000 |
| Stock issued for asset acquisition | - | - | 50,000 | 500 | 302,500 | - | - | 303,000 | - | 303,000 |
| Series A Preferred Stock Dividend | - | - | - | - | - | (776,562) | - | (776,562) | - | (776,562) |
| Distribution to non-controlling interest | - | - | - | - | - | - | - | - | (276,119) | (276,119) |
| Net (loss) income | - | - | - | - | - | (1,619,664) | - | (1,619,664) | 505,075 | (1,114,589) |
| Balance, June 30, 2025 | 1,400,000 | $140 | 45,141,226 | $451,412 | $236,426,008 | $(243,207,498) | $(163,701) | $(6,493,639) | $2,253,895 | $(4,239,744) |
| Series A Preferred Stock · Common Stock · Additional Paid-in · Accumulated · Treasury | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares | Amount | Shares | Amount | Capital | Deficit | Stock | Total | |
| Balance, January 1, 2026 | 1,400,000 | $140 | 46,760,016 | $467,600 | $251,455,616 | $(228,603,075) | $(163,701) | $23,156,580 |
| Stock compensation expense | - | - | 819,691 | 8,197 | 1,440,708 | - | - | 1,448,905 |
| Exercise of stock options | - | - | 53,000 | 530 | 79,990 | - | - | 80,520 |
| Series A Preferred Stock Dividend | - | - | - | - | - | (776,563) | - | (776,563) |
| Net loss | - | - | - | - | - | (8,872,596) | - | (8,872,596) |
| Balance, March 31, 2026 | 1,400,000 | $140 | 47,632,707 | $476,327 | $252,976,314 | $(238,252,234) | $(163,701) | $15,036,846 |
| Stock compensation expense | - | - | 290,825 | 2,908 | 787,204 | - | - | 790,112 |
| Series A Preferred Stock Dividend | - | - | - | - | - | (776,562) | - | (776,562) |
| Net loss | - | - | - | - | - | (7,083,941) | - | (7,083,941) |
| Balance, June 30, 2026 | 1,400,000 | $140 | 47,923,532 | 479,235 | 253,763,518 | (246,112,737) | $(163,701) | 7,966,455 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.